產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | RBE (人肝膽管癌細(xì)胞) (STR鑒定正確) |
種屬 | 人 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:3 |
推薦換液頻率 | 2-3次/周 |
背景描述 | RBE細(xì)胞是一株人肝膽管癌細(xì)胞;據(jù)說,RBE細(xì)胞可產(chǎn)CEA和CA19-9。 |
年齡(性別) | 女性 |
組織來源 | 肝 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 肝膽癌細(xì)胞 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 12 D2S1338 17,24 D3S1358 14,15 D5S818 11,12 D7S820 8,11 D8S1179 13,14 D13S317 9 D16S539 10,11 D18S51 13,15 D19S433 14,15.2 D21S11 29 FGA 19,24 PentaD 12 PentaE 18 TH01 6 TPOX 8 vWA 20 D6S1043 14 D12S391 18 D2S441 10,11 -
STR鑒定圖
參考文獻(xiàn)
-
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10(2022/12/07)
作者:Jingli Cai, Zheng Cui, Jingyi Zhou
期刊:Cancer Cell International
DOI:10.1186/s12935-022-02809-2
影響因子 :5.800
-
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma(2020/11/10)
作者:Xiangyu Zhai, Wei Wang, Yunlong Ma
期刊:Aging-US
影響因子 :5.200
-
Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma(2023/06/05)
作者:Wei Zhao, Jing Zhao, Kun Li
期刊:LABORATORY INVESTIGATION
DOI:10.1016/j.labinv.2023.100193
影響因子 :5.000
-
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis(2023/03/01)
作者:Fanghua Chen, Ling Aye, Lei Yu
期刊:CARCINOGENESIS
影響因子 :4.700
引用產(chǎn)品:CL-0191
-
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis(2024/02/28)
作者:Chao Zhang, Chengkun Qin
期刊:Human Cell
DOI:10.1007/s13577-024-01032-7
影響因子 :4.300
引用產(chǎn)品:CL-0191
-
LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway(2023/11/11)
作者:Guoqing Zhou, Hongwei He, Xuan Wang
期刊:Heliyon
DOI:10.1016/j.heliyon.2023.e22087
影響因子 :4.000
引用產(chǎn)品:CL-0191
-
Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin(2018/05/25)
作者:Qixiang Ma, Yanyan Feng, Kaiwen Deng
期刊:Journal of Cancer
影響因子 :3.900
-
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis(2021/2/8)
作者:Wei Zhao, Jing Zhao, Xiao Guo
期刊:Bmc Cancer
DOI:10.1186/s12885-021-07838-0
影響因子 :3.800
-
Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1(2024/04/04)
作者:Jiong Li, Xiangjun Ma, Faying Xu
期刊:PHARMACEUTICAL BIOLOGY
DOI:10.1080/13880209.2024.2331060
影響因子 :3.800
引用產(chǎn)品:CL-0191
-
Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules(2023/02/16)
作者:Yanfei Chu, Doufei Shi, Nan Wang
期刊:Parasites & Vectors
DOI:10.1186/s13071-023-05694-4
影響因子 :3.200
引用產(chǎn)品:CL-0191
-
Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma(2022/12/06)
作者:Jintian Tang, Runjuan Tang, Peng Gu
期刊:HUMAN & EXPERIMENTAL TOXICOLOGY
影響因子 :2.800
-
Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.(2022/11/04)
作者:Sun J, Feng M, Zou H, Mao Y, Yu W
期刊:HISTOLOGY AND HISTOPATHOLOGY
影響因子 :2.000
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識別碼示意圖